The present disclosure relates to compositions of Mothers Against Decapentaplegic Homolog 7 (SMAD7) antisense nucleotides and methods of using the composition in treating, preventing, and/or ameliorating a skin inflammation, e.g., psoriasis, or symptoms thereof.